Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

Published:2024-04 Issue: Volume:342 Page:122538
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Zhou Shuyan,Zhang Qiangsheng,Yang Honglin,Zhu Yongxia,Hu Xiang,Wan Guoquan,Yu Luoting

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Sichuan University

Sichuan University West China Hospital

Publisher

Elsevier BV

Reference130 articles.

1. Asthma

2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Lancet,2020

3. Lung cancer;Thai;Lancet,2021

4. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Soriano;Lancet Respir. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP